U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828068) titled 'Using Radiation-free Ultrasound for Screening Scoliosis Among Female School Children in Hon... Read More
U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06827769) titled 'Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients' on Feb. 04. Brief Summar... Read More
U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06826768) titled 'A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC' on Feb. 10. Brief Summar... Read More
U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06826612) titled 'A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease' on ... Read More
U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06826781) titled 'Evaluating Q-Collar Effects on Brain Blood Flow Control During Exercise' on Feb. 07. Brief... Read More
U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828081) titled 'Comparative Effects of Getting it Right Addressing Shoulder Pain and Rotator Cuff Strengthe... Read More
U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06827210) titled 'Treatment of Bulbar Urethral Strictures With Optilume Drug-Coated Balloons in an Untreated ... Read More
U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828601) titled 'Perioperative Lidocaine Infusions for the Management of Pain from Burn Injury' on Jan. 22, ... Read More
U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06826469) titled 'The Efficacy and Safety of Task-state-based Temporal Interference Stimulation (TI) in the T... Read More
U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828055) titled 'VK2735 for Weight Management Phase 2 (Venture Oral Dosing)' on Feb. 10. Brief Summary: Thi... Read More